Work

Comparative Risk of Serious Infection With Vedolizumab vs Anti–Tumor Necrosis Factors in Inflammatory Bowel Disease

Year: 2024

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.14309/ajg.0000000000002995

Authors: Cong Dai, Yu-hong Huang, Min Jiang

Institutions: First Hospital of China Medical University, China Medical University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401701639

FWCI: 0.245

Cites: 5

Cited by: 1

Related to: 10